{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:55:38Z","timestamp":1791665738695,"version":"4.3.4"},"reference-count":221,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Motor neuron diseases (MNDs) are a heterogeneous group of neurodegenerative disorders characterized by the progressive loss of motor neurons, resulting in debilitating physical decline. Advances in genetics have revolutionized the understanding of MNDs, elucidating critical genes such as SOD1, TARDBP, FUS, and C9orf72, which are implicated in their pathogenesis. Despite these breakthroughs, significant gaps persist in understanding the interplay between genetic and environmental factors, the role of rare variants, and epigenetic contributions. This review synthesizes current knowledge on the genetic landscape of MNDs, highlights challenges in linking genotype to phenotype, and discusses the promise of precision medicine approaches. Emphasis is placed on emerging strategies, such as gene therapy and targeted molecular interventions, offering hope for personalized treatments. Addressing these challenges is imperative to harness the full potential of genomics for improving outcomes in MNDs.<\/jats:p>","DOI":"10.3390\/ijms26104904","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:33:47Z","timestamp":1747733627000},"page":"4904","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic Basis of Motor Neuron Diseases: Insights, Clinical Management, and Future Directions"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9806-8010","authenticated-orcid":false,"given":"Apostolos","family":"Antonakoudis","sequence":"first","affiliation":[{"name":"Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8622-9318","authenticated-orcid":false,"given":"Stella Aikaterini","family":"Kyriakoudi","sequence":"additional","affiliation":[{"name":"Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2200-392X","authenticated-orcid":false,"given":"Despoina","family":"Chatzi","sequence":"additional","affiliation":[{"name":"Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9134-1083","authenticated-orcid":false,"given":"Iasonas","family":"Dermitzakis","sequence":"additional","affiliation":[{"name":"Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4280-0933","authenticated-orcid":false,"given":"Sofia","family":"Gargani","sequence":"additional","affiliation":[{"name":"Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soultana","family":"Meditskou","sequence":"additional","affiliation":[{"name":"Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-878X","authenticated-orcid":false,"given":"Maria Eleni","family":"Manthou","sequence":"additional","affiliation":[{"name":"Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-6695","authenticated-orcid":false,"given":"Paschalis","family":"Theotokis","sequence":"additional","affiliation":[{"name":"Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2018.07.012","article-title":"Motor Neuron Disease: Pathophysiology, Diagnosis, and Management","volume":"132","author":"Foster","year":"2019","journal-title":"Am. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11136-024-03611-5","article-title":"Quality of Life, Cognitive and Behavioural Impairment in People with Motor Neuron Disease: A Systematic Review","volume":"33","author":"Radakovic","year":"2024","journal-title":"Qual. Life Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/CON.0000000000000911","article-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases","volume":"26","author":"Quinn","year":"2020","journal-title":"Continuum Lifelong Learn. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.1999.tb00217.x","article-title":"Oxidative Stress and Motor Neurone Disease","volume":"9","author":"Cookson","year":"1999","journal-title":"Brain Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Xu, J., Su, X., Burley, S.K., and Zheng, X.F.S. (2022). Nuclear SOD1 in Growth Control, Oxidative Stress Response, Amyotrophic Lateral Sclerosis, and Cancer. Antioxidants, 11.","DOI":"10.3390\/antiox11020427"},{"key":"ref_6","unstructured":"Brotman, R.G., Moreno-Escobar, M.C., Joseph, J., Munakomi, S., and Pawar, G. (2024). Amyotrophic Lateral Sclerosis. StatPearls, StatPearls Publishing."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic Lateral Sclerosis: A Clinical Review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Araki, T. (2021). Clinical Manifestation and Management of Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis, Exon Publications.","DOI":"10.36255\/exonpublications.amyotrophiclateralsclerosis.2021"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/1673-5374.314289","article-title":"Lower and Upper Motor Neuron Involvement and Their Impact on Disease Prognosis in Amyotrophic Lateral Sclerosis","volume":"17","author":"Zakharova","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tena, A., Clari\u00e0, F., Solsona, F., and Povedano, M. (2022). Detecting Bulbar Involvement in Patients with Amyotrophic Lateral Sclerosis Based on Phonatory and Time-Frequency Features. Sensors, 22.","DOI":"10.3390\/s22031137"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/17482960701656940","article-title":"Causes of Death in a Post-Mortem Series of ALS Patients","volume":"9","author":"Corcia","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jns.2019.02.030","article-title":"Genetics of Amyotrophic Lateral Sclerosis: A Review","volume":"399","author":"Mathis","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_13","first-page":"65","article-title":"Genetics of Familial Amyotrophic Lateral Sclerosis","volume":"149","author":"Ticozzi","year":"2011","journal-title":"Arch. Ital. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.0000000000004109","article-title":"The Evolving Genetic Risk for Sporadic ALS","volume":"89","author":"Gibson","year":"2017","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hemerkov\u00e1, P., and Vali\u0161, M. (2021). Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies. Biomolecules, 11.","DOI":"10.3390\/biom11030437"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","article-title":"Oxidative Stress in ALS: A Mechanism of Neurodegeneration and a Therapeutic Target","volume":"1762","author":"Barber","year":"2006","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative Stress: Harms and Benefits for Human Health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Chaudhary, P., Janmeda, P., Docea, A.O., Yeskaliyeva, B., Abdull Razis, A.F., Modu, B., Calina, D., and Sharifi-Rad, J. (2023). Oxidative Stress, Free Radicals and Antioxidants: Potential Crosstalk in the Pathophysiology of Human Diseases. Front. Chem., 11.","DOI":"10.3389\/fchem.2023.1158198"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0891-5849(02)00905-X","article-title":"Superoxide Dismutase Multigene Family: A Comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) Gene Structures, Evolution, and Expression","volume":"33","author":"Zelko","year":"2002","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1038\/ncomms4446","article-title":"Superoxide Dismutase 1 Acts as a Nuclear Transcription Factor to Regulate Oxidative Stress Resistance","volume":"5","author":"Tsang","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.ymthe.2024.01.031","article-title":"SOD2 Promotes the Immunosuppressive Function of Mesenchymal Stem Cells at the Expense of Adipocyte Differentiation","volume":"32","author":"Li","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Parascandolo, A., and Laukkanen, M.O. (2021). SOD3 Is a Non-Mutagenic Growth Regulator Affecting Cell Migration and Proliferation Signal Transduction. Antioxidants, 10.","DOI":"10.3390\/antiox10050635"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zgorzynska, E., Dziedzic, B., and Walczewska, A. (2021). An Overview of the Nrf2\/ARE Pathway and Its Role in Neurodegenerative Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179592"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"878030","DOI":"10.1155\/2012\/878030","article-title":"Nrf2\/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS","volume":"2012","author":"Petri","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cbi.2013.12.005","article-title":"Nrf2\/ARE Pathway Activation, HO-1 and NQO1 Induction by Polychlorinated Biphenyl Quinone Is Associated with Reactive Oxygen Species and PI3K\/AKT Signaling","volume":"209","author":"Li","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Harvey, C.J., Thimmulappa, R.K., Singh, A., Blake, D.J., Ling, G., Wakabayashi, N., Fujii, J., Myers, A., and Biswal, S. (2008). Nrf2-Regulated Glutathione Recycling Independent of Biosynthesis Is Critical for Cell Survival during Oxidative Stress. Free. Radic. Biol. Med., 46.","DOI":"10.1016\/j.freeradbiomed.2008.10.040"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1002\/jcp.26416","article-title":"Role of Nrf2 in Preventing Oxidative Stress Induced Chloride Current Alteration in Human Lung Cells","volume":"233","author":"Canella","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"113247","DOI":"10.1016\/j.expneurol.2020.113247","article-title":"Transcriptional Activation of Antioxidant Gene Expression by Nrf2 Protects against Mitochondrial Dysfunction and Neuronal Death Associated with Acute and Chronic Neurodegeneration","volume":"328","author":"Goodfellow","year":"2020","journal-title":"Exp. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Vomund, S., Sch\u00e4fer, A., Parnham, M.J., Br\u00fcne, B., and von Knethen, A. (2017). Nrf2, the Master Regulator of Anti-Oxidative Responses. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122772"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13024-021-00479-8","article-title":"Impaired Antioxidant KEAP1-NRF2 System in Amyotrophic Lateral Sclerosis: NRF2 Activation as a Potential Therapeutic Strategy","volume":"16","author":"Bono","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1073\/pnas.1815961116","article-title":"Cytotoxic CD8+ T Lymphocytes Expressing ALS-Causing SOD1 Mutant Selectively Trigger Death of Spinal Motoneurons","volume":"116","author":"Coque","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mead, R.J., Bennett, E.J., Kennerley, A.J., Sharp, P., Sunyach, C., Kasher, P., Berwick, J., Pettmann, B., Battaglia, G., and Azzouz, M. (2011). Optimised and Rapid Pre-Clinical Screening in the SOD1(G93A) Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS). PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023244"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/01.wnl.0000343509.76828.2a","article-title":"Age and Founder Effect of SOD1 A4V Mutation Causing ALS","volume":"72","author":"Saeed","year":"2009","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Arslanbaeva, L., and Bisaglia, M. (2022). Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment. Molecules, 27.","DOI":"10.3390\/molecules27051471"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1471-4159.2008.05799.x","article-title":"Recruitment of Mitochondria into Apoptotic Signaling Correlates with the Presence of Inclusions Formed by Amyotrophic Lateral Sclerosis-Associated SOD1 Mutations","volume":"108","author":"Soo","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1089\/ars.2009.2545","article-title":"Oligomerization of Mutant SOD1 in Mitochondria of Motoneuronal Cells Drives Mitochondrial Damage and Cell Toxicity","volume":"11","author":"Cozzolino","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tafuri, F., Ronchi, D., Magri, F., Comi, G.P., and Corti, S. (2015). SOD1 Misplacing and Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis Pathogenesis. Front. Cell Neurosci., 9.","DOI":"10.3389\/fncel.2015.00336"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"40151","DOI":"10.1074\/jbc.M111.279711","article-title":"Alsin and SOD1(G93A) Proteins Regulate Endosomal Reactive Oxygen Species Production by Glial Cells and Proinflammatory Pathways Responsible for Neurotoxicity","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13046","DOI":"10.1073\/pnas.1002396107","article-title":"Mutant Superoxide Dismutase 1-Induced IL-1\u03b2 Accelerates ALS Pathogenesis","volume":"107","author":"Meissner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3390\/cimb45030171","article-title":"Origin and Emergence of Microglia in the CNS\u2014An Interesting (Hi)Story of an Eccentric Cell","volume":"45","author":"Dermitzakis","year":"2023","journal-title":"CIMB"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1096\/fj.03-1199fje","article-title":"Cell Death in Amyotrophic Lateral Sclerosis: Interplay between Neuronal and Glial Cells","volume":"18","author":"Ferri","year":"2004","journal-title":"FASEB J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes Expressing ALS-Linked Mutated SOD1 Release Factors Selectively Toxic to Motor Neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fnagi.2017.00242","article-title":"The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches","volume":"9","author":"Geloso","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Peggion, C., Scalcon, V., Massimino, M.L., Nies, K., Lopreiato, R., Rigobello, M.P., and Bertoli, A. (2022). SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells. Antioxidants, 11.","DOI":"10.3390\/antiox11040614"},{"key":"ref_47","first-page":"83","article-title":"RNA-Binding Proteins and RNA Metabolism: A New Scenario in the Pathogenesis of Amyotrophic Lateral Sclerosis","volume":"149","author":"Colombrita","year":"2011","journal-title":"Arch. Ital. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.molmed.2011.06.004","article-title":"TDP-43 Functions and Pathogenic Mechanisms Implicated in TDP-43 Proteinopathies","volume":"17","author":"Cohen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41583-021-00431-1","article-title":"Triad of TDP43 Control in Neurodegeneration: Autoregulation, Localization and Aggregation","volume":"22","author":"Tziortzouda","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.semcdb.2019.05.023","article-title":"Cytoplasmic Functions of TDP-43 and FUS and Their Role in ALS","volume":"99","author":"Birsa","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-020-02205-y","article-title":"TDP-43 Transports Ribosomal Protein mRNA to Regulate Axonal Local Translation in Neuronal Axons","volume":"140","author":"Nagano","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7150\/thno.51004","article-title":"TDP-43 Proteinopathy Impairs mRNP Granule Mediated Postsynaptic Translation and mRNA Metabolism","volume":"11","author":"Wong","year":"2021","journal-title":"Theranostics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e13215","DOI":"10.1111\/bpa.13215","article-title":"Colocalization of TDP-43 and Stress Granules at the Early Stage of TDP-43 Aggregation in Amyotrophic Lateral Sclerosis","volume":"34","author":"Mori","year":"2024","journal-title":"Brain Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2012.02.032","article-title":"TDP-43 Aggregation in Neurodegeneration: Are Stress Granules the Key?","volume":"1462","author":"Dewey","year":"2012","journal-title":"Brain Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Rutherford, N.J., Zhang, Y.-J., Baker, M., Gass, J.M., Finch, N.A., Xu, Y.-F., Stewart, H., Kelley, B.J., Kuntz, K., and Crook, R.J.P. (2008). Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis. PLoS Genet., 4.","DOI":"10.1371\/journal.pgen.1000193"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12035-013-8427-5","article-title":"Overexpression of ALS-Associated p.M337V Human TDP-43 in Mice Worsens Disease Features Compared to Wild-Type Human TDP-43 Mice","volume":"48","author":"Janssens","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/prot.26482","article-title":"Influence of ALS-Linked M337V Mutation on the Conformational Ensembles of TDP-43321-340 Peptide Monomer and Dimer","volume":"92","author":"Zeng","year":"2024","journal-title":"Proteins"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/neup.12559","article-title":"P.N345K Mutation in TARDBP in a Patient with Familial Amyotrophic Lateral Sclerosis: An Autopsy Case","volume":"39","author":"Takeda","year":"2019","journal-title":"Neuropathology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.3233\/JAD-2012-129036","article-title":"TARDBP Mutation Analysis in TDP-43 Proteinopathies and Deciphering the Toxicity of Mutant TDP-43","volume":"33","author":"Gendron","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","article-title":"Genetic Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis","volume":"88","author":"Zou","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The Role of TDP-43 Mislocalization in Amyotrophic Lateral Sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-010-0786-7","article-title":"Cytoplasmic Accumulation of TDP-43 in Circulating Lymphomonocytes of ALS Patients with and without TARDBP Mutations","volume":"121","author":"Lupino","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","article-title":"Cytoplasmic Mislocalization of TDP-43 Is Toxic to Neurons and Enhanced by a Mutation Associated with Familial Amyotrophic Lateral Sclerosis","volume":"30","author":"Barmada","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Wood, A., Gurfinkel, Y., Polain, N., Lamont, W., and Lyn Rea, S. (2021). Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094705"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Pakravan, D., Michiels, E., Bratek-Skicki, A., De Decker, M., Van Lindt, J., Alsteens, D., Derclaye, S., Van Damme, P., Schymkowitz, J., and Rousseau, F. (2021). Liquid-Liquid Phase Separation Enhances TDP-43 LCD Aggregation but Delays Seeded Aggregation. Biomolecules, 11.","DOI":"10.3390\/biom11040548"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Carey, J.L., and Guo, L. (2022). Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.826719"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21678421.2023.2272170","article-title":"FUS Gene Mutation in Amyotrophic Lateral Sclerosis: A New Case Report and Systematic Review","volume":"25","author":"Xiao","year":"2024","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"a026757","DOI":"10.1101\/cshperspect.a026757","article-title":"The Genetics of C9orf72 Expansions","volume":"8","author":"Gijselinck","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature14974","article-title":"GGGGCC Repeat Expansion in C9orf72 Compromises Nucleocytoplasmic Transport","volume":"525","author":"Freibaum","year":"2015","journal-title":"Nature"},{"key":"ref_71","unstructured":"Orrell, R.W. (2021). ALS2-Related Disorder. GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 Intermediate-Length Polyglutamine Expansions Are Associated with Increased Risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fob.2013.11.001","article-title":"The ALS\/FTLD-Related RNA-Binding Proteins TDP-43 and FUS Have Common Downstream RNA Targets in Cortical Neurons","volume":"4","author":"Honda","year":"2014","journal-title":"FEBS Open Bio"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-016-0358-8","article-title":"Pathogenesis of FUS-Associated ALS and FTD: Insights from Rodent Models","volume":"4","author":"Nolan","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12015-022-10489-8","article-title":"Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects","volume":"19","author":"Assoni","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jnc.13601","article-title":"Altered mRNP Granule Dynamics in FTLD Pathogenesis","volume":"138","author":"Bowden","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.neuron.2018.09.044","article-title":"ALS\/FTD-Linked Mutation in FUS Suppresses Intra-Axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS","volume":"100","author":"Tadokoro","year":"2018","journal-title":"Neuron"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/emboj.2010.143","article-title":"ALS-Associated Fused in Sarcoma (FUS) Mutations Disrupt Transportin-Mediated Nuclear Import","volume":"29","author":"Dormann","year":"2010","journal-title":"EMBO J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.4161\/cc.26241","article-title":"Recruitment into Stress Granules Prevents Irreversible Aggregation of FUS Protein Mislocalized to the Cytoplasm","volume":"12","author":"Shelkovnikova","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"An, H., Litscher, G., Watanabe, N., Wei, W., Hashimoto, T., Iwatsubo, T., Buchman, V.L., and Shelkovnikova, T.A. (2022). ALS-Linked Cytoplasmic FUS Assemblies Are Compositionally Different from Physiological Stress Granules and Sequester hnRNPA3, a Novel Modifier of FUS Toxicity. Neurobiol. Dis., 162.","DOI":"10.1016\/j.nbd.2021.105585"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s13311-015-0340-3","article-title":"Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis","volume":"12","author":"Barmada","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.15252\/embj.201592559","article-title":"Toxic Gain of Function from Mutant FUS Protein Is Crucial to Trigger Cell Autonomous Motor Neuron Loss","volume":"35","author":"Sendscheid","year":"2016","journal-title":"EMBO J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1242\/dmm.028613","article-title":"RNA Metabolism in Neurodegenerative Disease","volume":"10","author":"Liu","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/hmg\/dds526","article-title":"RNA-Binding Ability of FUS Regulates Neurodegeneration, Cytoplasmic Mislocalization and Incorporation into Stress Granules Associated with FUS Carrying ALS-Linked Mutations","volume":"22","author":"Daigle","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","article-title":"TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets","volume":"12","author":"Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3349\/ymj.2021.62.4.338","article-title":"Clinical Course of Amyotrophic Lateral Sclerosis According to Initial Symptoms: An Analysis of 500 Cases","volume":"62","author":"Lee","year":"2021","journal-title":"Yonsei Med. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s13311-022-01260-5","article-title":"Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS\/FTD","volume":"19","author":"Hayes","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/cns.13305","article-title":"Genetic Testing of FUS, HTRA2, and TENM4 Genes in Chinese Patients with Essential Tremor","volume":"26","author":"Yan","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 Is Required for Proper Macrophage and Microglial Function in Mice","volume":"351","author":"Bogdanik","year":"2016","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cmet.2021.01.005","article-title":"C9orf72 Regulates Energy Homeostasis by Stabilizing Mitochondrial Complex I Assembly","volume":"33","author":"Wang","year":"2021","journal-title":"Cell Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1080\/15548627.2021.1872189","article-title":"C9orf72 ALS-FTD: Recent Evidence for Dysregulation of the Autophagy-Lysosome Pathway at Multiple Levels","volume":"17","author":"Beckers","year":"2021","journal-title":"Autophagy"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e202101276","DOI":"10.26508\/lsa.202101276","article-title":"C9ORF72-Derived Poly-GA DPRs Undergo Endocytic Uptake in iAstrocytes and Spread to Motor Neurons","volume":"5","author":"Marchi","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jnc.15255","article-title":"Cellular and Physiological Functions of C9ORF72 and Implications for ALS\/FTD","volume":"157","author":"Pang","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Ratti, A., Gumina, V., Lenzi, P., Bossolasco, P., Fulceri, F., Volpe, C., Bardelli, D., Pregnolato, F., Maraschi, A., and Fornai, F. (2020). Chronic Stress Induces Formation of Stress Granules and Pathological TDP-43 Aggregates in Human ALS Fibroblasts and iPSC-Motoneurons. Neurobiol. Dis., 145.","DOI":"10.1016\/j.nbd.2020.105051"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kumar, V., Hasan, G.M., and Hassan, M.I. (2017). Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD\/ALS. Front. Neurosci., 11.","DOI":"10.3389\/fnins.2017.00711"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1007\/s12035-016-9850-1","article-title":"C9ORF72 Regulates Stress Granule Formation and Its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress","volume":"54","author":"Maharjan","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nn.4065","article-title":"Distinct Brain Transcriptome Profiles in C9orf72-Associated and Sporadic ALS","volume":"18","author":"Prudencio","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","article-title":"Antisense Transcripts of the Expanded C9ORF72 Hexanucleotide Repeat Form Nuclear RNA Foci and Undergo Repeat-Associated Non-ATG Translation in c9FTD\/ALS","volume":"126","author":"Gendron","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e100574","DOI":"10.15252\/embj.2018100574","article-title":"Reduced Autophagy upon C9ORF72 Loss Synergizes with Dipeptide Repeat Protein Toxicity in G4C2 Repeat Expansion Disorders","volume":"39","author":"Boivin","year":"2020","journal-title":"EMBO J."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Geng, Y., and Cai, Q. (2024). Role of C9orf72 Hexanucleotide Repeat Expansions in ALS\/FTD Pathogenesis. Front. Mol. Neurosci., 17.","DOI":"10.3389\/fnmol.2024.1322720"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/hmg\/ddy174","article-title":"C9ORF72 Dipeptide Repeat Poly-GA Inclusions Promote Intracellular Aggregation of Phosphorylated TDP-43","volume":"27","author":"Nonaka","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuint.2007.04.010","article-title":"Molecular and Cellular Function of ALS2\/Alsin: Implication of Membrane Dynamics in Neuronal Development and Degeneration","volume":"51","author":"Hadano","year":"2007","journal-title":"Neurochem. Int."},{"key":"ref_104","unstructured":"(2024, September 14). ALS2\u2014An Overview | ScienceDirect Topics. Available online: https:\/\/www.sciencedirect.com\/topics\/biochemistry-genetics-and-molecular-biology\/als2."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e32282","DOI":"10.7554\/eLife.32282","article-title":"Rab5 and Alsin Regulate Stress-Activated Cytoprotective Signaling on Mitochondria","volume":"7","author":"Hsu","year":"2018","journal-title":"Elife"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Cai, Q., and Ganesan, D. (2022). Regulation of Neuronal Autophagy and the Implications in Neurodegenerative Diseases. Neurobiol. Dis., 162.","DOI":"10.1016\/j.nbd.2021.105582"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12035-007-0034-x","article-title":"Alsin and the Molecular Pathways of Amyotrophic Lateral Sclerosis","volume":"36","author":"Chandran","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-6606-2-23","article-title":"Regulation of Endosomal Motility and Degradation by Amyotrophic Lateral Sclerosis 2\/Alsin","volume":"2","author":"Lai","year":"2009","journal-title":"Mol. Brain"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/hmg\/ddg184","article-title":"ALS2, a Novel Guanine Nucleotide Exchange Factor for the Small GTPase Rab5, Is Implicated in Endosomal Dynamics","volume":"12","author":"Otomo","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/1873-3468.13306","article-title":"Rab5 Activation on Macropinosomes Requires ALS2, and Subsequent Rab5 Inactivation through ALS2 Detachment Requires Active Rab7","volume":"593","author":"Morishita","year":"2019","journal-title":"FEBS Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: Cellular and Molecular Mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An Overview of Autophagy: Morphology, Mechanism, and Regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxid. Redox signaling"},{"key":"ref_113","unstructured":"(2024, September 14). The Interplay Between Oxidative Stress and Autophagy: Focus on the Development of Neurological Diseases-PMC, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8799983\/."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/cdd.2014.150","article-title":"Oxidative Stress and Autophagy: The Clash between Damage and Metabolic Needs","volume":"22","author":"Filomeni","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1523\/JNEUROSCI.1645-05.2005","article-title":"Loss of ALS2 Function Is Insufficient to Trigger Motor Neuron Degeneration in Knock-Out Mice But Predisposes Neurons to Oxidative Stress","volume":"25","author":"Cai","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Yun, H.R., Jo, Y.H., Kim, J., Shin, Y., Kim, S.S., and Choi, T.G. (2020). Roles of Autophagy in Oxidative Stress. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093289"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Cannariato, M., Miceli, M., Cavagli\u00e0, M., and Deriu, M.A. (2021). Prediction of Protein-Protein Interactions Between Alsin DH\/PH and Rac1 and Resulting Protein Dynamics. Front. Mol. Neurosci., 14.","DOI":"10.3389\/fnmol.2021.772122"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/hmg\/ddv631","article-title":"Absence of Alsin Function Leads to Corticospinal Motor Neuron Vulnerability via Novel Disease Mechanisms","volume":"25","author":"Gautam","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Yoganathan, S., Kumar, M., Aaron, R., Rangan, S.R., Umakant, B.S., Thomas, M., Oommen, S.P., and Danda, S. (2024). Phenotype and Genotype of Children with ALS2 Gene-Related Disorder. Neuropediatrics.","DOI":"10.1055\/s-0044-1791256"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ajmg.a.61951","article-title":"Genotype-Phenotype Correlation in Seven Motor Neuron Disease Families with Novel ALS2 Mutations","volume":"185","author":"Sprute","year":"2021","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2421.e13","DOI":"10.1016\/j.neurobiolaging.2014.04.016","article-title":"Ataxin-2 as Potential Disease Modifier in C9ORF72 Expansion Carriers","volume":"35","author":"Mullen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.devcel.2024.09.023","article-title":"Ataxin-2 Polyglutamine Expansions Aberrantly Sequester TDP-43 Ribonucleoprotein Condensates Disrupting mRNA Transport and Local Translation in Neurons","volume":"60","author":"Wijegunawardana","year":"2024","journal-title":"Dev. Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/WCO.0000000000000959","article-title":"Ataxin-2 Gene: A Powerful Modulator of Neurological Disorders","volume":"34","author":"Paucar","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal Muscular Atrophy","volume":"8","author":"Mercuri","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_125","unstructured":"(2024, November 23). Spinal Muscular Atrophy|National Institute of Neurological Disorders and Stroke, Available online: https:\/\/www.ninds.nih.gov\/health-information\/disorders\/spinal-muscular-atrophy."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e8513","DOI":"10.1002\/ccr3.8513","article-title":"Spinal Muscular Atrophy Type 1: A Fatal Case in a 1-Year-Old Girl with Delayed Diagnosis","volume":"12","author":"Rizvi","year":"2024","journal-title":"Clin. Case Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13023-022-02455-x","article-title":"Natural History of Type 1 Spinal Muscular Atrophy: A Retrospective, Global, Multicenter Study","volume":"17","author":"Cances","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"7S18","DOI":"10.1016\/S0929-693X(20)30272-4","article-title":"Clinical Features of Spinal Muscular Atrophy (SMA) Type 2","volume":"27","author":"Richelme","year":"2020","journal-title":"Arch. Pediatr."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"7S23","DOI":"10.1016\/S0929-693X(20)30273-6","article-title":"Clinical Features of Spinal Muscular Atrophy (SMA) Type 3 (Kugelberg-Welander Disease)","volume":"27","year":"2020","journal-title":"Arch. Pediatr."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/ene.14587","article-title":"Clinical and Radiological Profile of Patients with Spinal Muscular Atrophy Type 4","volume":"28","author":"Souza","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-1119(01)00758-2","article-title":"The SMN Genes Are Subject to Transcriptional Regulation during Cellular Differentiation","volume":"279","author":"Brun","year":"2001","journal-title":"Gene"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene","volume":"85","author":"Prior","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_133","unstructured":"(2024, November 23). SMN1 Survival of Motor Neuron 1, Telomeric [Homo Sapiens (Human)]-Gene-NCBI, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/6606."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2012.02.051","article-title":"Spliceosomal Small Nuclear Ribonucleoprotein Biogenesis Defects and Motor Neuron Selectivity in Spinal Muscular Atrophy","volume":"1462","author":"Workman","year":"2012","journal-title":"Brain Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2012.01.044","article-title":"Spinal Muscular Atrophy: The Role of SMN in Axonal mRNA Regulation","volume":"1462","author":"Fallini","year":"2012","journal-title":"Brain Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.celrep.2017.01.059","article-title":"The Survival of Motor Neuron Protein Acts as a Molecular Chaperone for mRNP Assembly","volume":"18","author":"Fallini","year":"2017","journal-title":"Cell Rep."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Karafoulidou, E., Kesidou, E., Theotokis, P., Konstantinou, C., Nella, M.-K., Michailidou, I., Touloumi, O., Polyzoidou, E., Salamotas, I., and Einstein, O. (2024). Systemic LPS Administration Stimulates the Activation of Non-Neuronal Cells in an Experimental Model of Spinal Muscular Atrophy. Cells, 13.","DOI":"10.3390\/cells13090785"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1007\/s00018-018-2849-1","article-title":"The Role of Survival Motor Neuron Protein (SMN) in Protein Homeostasis","volume":"75","author":"Chaytow","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_139","first-page":"446","article-title":"[Pseudodominant inheritance of spinal muscular atrophy\u2014Father and son suffering from SMA]","volume":"40","author":"Jedrzejowska","year":"2006","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An Update of the Mutation Spectrum of the Survival Motor Neuron Gene (SMN1) in Autosomal Recessive Spinal Muscular Atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum. Mutat."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal Muscular Atrophy: Why Do Low Levels of SMN Make Motor Neurons Sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41419-023-05573-x","article-title":"Dysfunctional Mitochondria Accumulate in a Skeletal Muscle Knockout Model of Smn1, the Causal Gene of Spinal Muscular Atrophy","volume":"14","author":"Chemello","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1074\/jbc.M108769200","article-title":"A Direct Interaction between the Survival Motor Neuron Protein and P53 and Its Relationship to Spinal Muscular Atrophy","volume":"277","author":"Young","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2018.02.022","article-title":"Spinal Muscular Atrophy: Selective Motor Neuron Loss and Global Defect in the Assembly of Ribonucleoproteins","volume":"1693","author":"Beattie","year":"2018","journal-title":"Brain Res."},{"key":"ref_145","unstructured":"(2024, November 25). SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in Splicing\u2013PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/18485868\/."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA Type and SMN2 Copy Number Revisited: An Analysis of 625 Unrelated Spanish Patients and a Compilation of 2834 Reported Cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Dosi, C., and Masson, R. (2024). The Impact of Three SMN2 Gene Copies on Clinical Characteristics and Effect of Disease-Modifying Treatment in Patients with Spinal Muscular Atrophy: A Systematic Literature Review. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1308296"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Vacchiano, V., Bonan, L., Liguori, R., and Rizzo, G. (2024). Primary Lateral Sclerosis: An Overview. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020578"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/practneurol-2019-002300","article-title":"Primary Lateral Sclerosis: Diagnosis and Management","volume":"20","author":"Turner","year":"2020","journal-title":"Pract. Neurol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archneur.64.2.232","article-title":"Differentiation between Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis: Examination of Symptoms and Signs at Disease Onset and during Follow-Up","volume":"64","author":"Tartaglia","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1212\/NXG.0000000000000060","article-title":"Compound Heterozygote Mutations in SPG7 in a Family with Adult-Onset Primary Lateral Sclerosis","volume":"2","author":"Yang","year":"2016","journal-title":"Neurol. Genet."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/brain\/awl104","article-title":"The First ALS2 Missense Mutation Associated with JPLS Reveals New Aspects of Alsin Biological Function","volume":"129","author":"Panzeri","year":"2006","journal-title":"Brain"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00415-018-8917-5","article-title":"Primary Lateral Sclerosis and the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum","volume":"265","author":"Agarwal","year":"2018","journal-title":"J. Neurol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Miceli, M., Exertier, C., Cavagli\u00e0, M., Gugole, E., Boccardo, M., Casaluci, R.R., Ceccarelli, N., De Maio, A., Vallone, B., and Deriu, M.A. (2022). ALS2-Related Motor Neuron Diseases: From Symptoms to Molecules. Biology, 11.","DOI":"10.3390\/biology11010077"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/01.WNL.0000048207.28790.25","article-title":"Infantile Ascending Hereditary Spastic Paralysis (IAHSP): Clinical Features in 11 Families","volume":"60","author":"Lesca","year":"2003","journal-title":"Neurology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000151295","article-title":"ALS2\/Alsin Knockout Mice and Motor Neuron Diseases","volume":"5","author":"Cai","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Yang, Q., Luo, J., Zhou, X., Yi, S., Tan, S., and Qin, Z. (2024). Clinical Features and Molecular Genetic Investigation of Infantile-Onset Ascending Hereditary Spastic Paralysis (IAHSP) in Two Chinese Siblings Caused by a Novel Splice Site ALS2 Variation. BMC Med. Genomics, 17.","DOI":"10.1186\/s12920-024-01805-x"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/342359","article-title":"Infantile-Onset Ascending Hereditary Spastic Paralysis Is Associated with Mutations in the Alsin Gene","volume":"71","author":"Lesca","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10072-020-04981-7","article-title":"Hereditary Spastic Paraplegia","volume":"42","author":"Murala","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Meyyazhagan, A., and Orlacchio, A. (2022). Hereditary Spastic Paraplegia: An Update. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031697"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parkreldis.2022.03.019","article-title":"Genetic, Structural and Clinical Analysis of Spastic Paraplegia 4","volume":"98","author":"Varghaei","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_162","unstructured":"Parodi, L., Rydning, S.L., Tallaksen, C., and Durr, A. (2019). Spastic Paraplegia 4. GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/stem.1569","article-title":"Loss of Spastin Function Results in Disease-Specific Axonal Defects in Human Pluripotent Stem Cell-Based Models of Hereditary Spastic Paraplegia","volume":"32","author":"Denton","year":"2014","journal-title":"Stem Cells"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Wali, G., Liyanage, E., Blair, N.F., Sutharsan, R., Park, J.-S., Mackay-Sim, A., and Sue, C.M. (2020). Oxidative Stress-Induced Axon Fragmentation Is a Consequence of Reduced Axonal Transport in Hereditary Spastic Paraplegia SPAST Patient Neurons. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00401"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/brain\/awv178","article-title":"Hereditary Spastic Paraplegia SPG4: What Is Known and Not Known about the Disease","volume":"138","author":"Solowska","year":"2015","journal-title":"Brain"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/humu.10105","article-title":"Mutation Analysis of the Spastin Gene (SPG4) in Patients in Germany with Autosomal Dominant Hereditary Spastic Paraplegia","volume":"20","author":"Sauter","year":"2002","journal-title":"Hum. Mutat."},{"key":"ref_167","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). Spastic Paraplegia 7. GeneReviews\u00ae, University of Washington."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/brain\/awh125","article-title":"A Clinical, Genetic and Biochemical Study of SPG7 Mutations in Hereditary Spastic Paraplegia","volume":"127","author":"Wilkinson","year":"2004","journal-title":"Brain"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1212\/01.wnl.0000201185.91110.15","article-title":"Mutation Analysis of the Paraplegin Gene (SPG7) in Patients with Hereditary Spastic Paraplegia","volume":"66","author":"Elleuch","year":"2006","journal-title":"Neurology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1007\/s00415-020-09861-w","article-title":"SPG7 Mutations in Amyotrophic Lateral Sclerosis: A Genetic Link to Hereditary Spastic Paraplegia","volume":"267","author":"Osmanovic","year":"2020","journal-title":"J. Neurol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ncl.2015.07.005","article-title":"Progressive Muscular Atrophy","volume":"33","author":"Liewluck","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-510X(00)00350-6","article-title":"Progressive Muscular Atrophy Variant of Familial Amyotrophic Lateral Sclerosis (PMA\/ALS)","volume":"177","author":"Cervenakova","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"van Blitterswijk, M., Vlam, L., van Es, M.A., van der Pol, W.-L., Hennekam, E.A.M., Dooijes, D., Schelhaas, H.J., van der Kooi, A.J., de Visser, M., and Veldink, J.H. (2012). Genetic Overlap between Apparently Sporadic Motor Neuron Diseases. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048983"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Cruz, S.D., and Cleveland, D.W. (2011). Understanding the Role of TDP-43 and FUS\/TLS in ALS and Beyond. Curr. Opin. Neurobiol., 21.","DOI":"10.1016\/j.conb.2011.05.029"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12031-015-0674-7","article-title":"Spinal and Bulbar Muscular Atrophy Overview","volume":"58","author":"Fischbeck","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pneurobio.2012.05.007","article-title":"Pathogenesis and Therapy of Spinal and Bulbar Muscular Atrophy (SBMA)","volume":"99","author":"Katsuno","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/978-1-4419-6448-9_6","article-title":"Clinical Features and Molecular Mechanisms of Spinal and Bulbar Muscular Atrophy (SBMA)","volume":"685","author":"Katsuno","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_178","unstructured":"Spada, A.L. (2022). Spinal and Bulbar Muscular Atrophy. GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-319-71779-1_5","article-title":"X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity","volume":"1049","author":"Cortes","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00109-004-0530-7","article-title":"Spinal and Bulbar Muscular Atrophy: Ligand-Dependent Pathogenesis and Therapeutic Perspectives","volume":"82","author":"Katsuno","year":"2004","journal-title":"J. Mol. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/hmg\/ddn310","article-title":"Mitochondrial Abnormalities in Spinal and Bulbar Muscular Atrophy","volume":"18","author":"Ranganathan","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/brain\/awac269","article-title":"Ligand-Free Mitochondria-Localized Mutant AR-Induced Cytotoxicity in Spinal Bulbar Muscular Atrophy","volume":"146","author":"Feng","year":"2023","journal-title":"Brain"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Desai, D., Stiene, D., Song, T., and Sadayappan, S. (2020). Distal Arthrogryposis and Lethal Congenital Contracture Syndrome\u2014An Overview. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00689"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/ajmg.a.31381","article-title":"Lethal Congenital Contracture Syndrome (LCCS) and Other Lethal Arthrogryposes in Finland\u2014An Epidemiological Study","volume":"140A","author":"Ritvanen","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_185","unstructured":"(2024, November 25). Lethal Congenital Contracture Syndrome 1-NIH Genetic Testing Registry (GTR)-NCBI, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gtr\/conditions\/C1854664\/."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/jmg.31.7.521","article-title":"Lethal Congenital Contracture Syndrome: Further Delineation and Genetic Aspects","volume":"31","author":"Vuopala","year":"1994","journal-title":"J. Med. Genet."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng.2007.65","article-title":"Mutations in mRNA Export Mediator GLE1 Result in a Fetal Motoneuron Disease","volume":"40","author":"Nousiainen","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1086\/520771","article-title":"Lethal Contractural Syndrome Type 3 (LCCS3) Is Caused by a Mutation in PIP5K1C, Which Encodes PIPKI Gamma of the Phophatidylinsitol Pathway","volume":"81","author":"Narkis","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"14179611417961","DOI":"10.3389\/fnmol.2024.1417961","article-title":"Epigenetics in the Formation of Pathological Aggregates in Amyotrophic Lateral Sclerosis","volume":"17","author":"Noches","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s13311-013-0205-6","article-title":"Aberrant Regulation of DNA Methylation in Amyotrophic Lateral Sclerosis: A New Target of Disease Mechanisms","volume":"10","author":"Martin","year":"2013","journal-title":"Neurotherapeutics"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Tsekrekou, M., Giannakou, M., Papanikolopoulou, K., and Skretas, G. (2024). Protein Aggregation and Therapeutic Strategies in SOD1- and TDP-43- Linked ALS. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1383453"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Al-Mahdawi, S., Virmouni, S.A., and Pook, M.A. (2014). The Emerging Role of 5-Hydroxymethylcytosine in Neurodegenerative Diseases. Front. Neurosci., 8.","DOI":"10.3389\/fnins.2014.00397"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","article-title":"HDAC6 Inhibition Reverses Axonal Transport Defects in Motor Neurons Derived from FUS-ALS Patients","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1523\/JNEUROSCI.23-06-02131.2003","article-title":"Cell Cycle Regulators in the Neuronal Death Pathway of Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase 1","volume":"23","author":"Nguyen","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","article-title":"Epigenetics in Amyotrophic Lateral Sclerosis: A Role for Histone Post Translational Modifications in Neurodegenerative Disease","volume":"204","author":"Bennett","year":"2019","journal-title":"Transl. Res."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Laneve, P., Tollis, P., and Caffarelli, E. (2021). RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910285"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Yashooa, R.K., Duranti, E., Conconi, D., Lavitrano, M., Mustafa, S.A., and Villa, C. (2025). Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020626"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ejhg.2012.293","article-title":"Genome-Wide Analysis Shows Association of Epigenetic Changes in Regulators of Rab and Rho GTPases with Spinal Muscular Atrophy Severity","volume":"21","author":"Zheleznyakova","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/j.1471-4159.2009.06084.x","article-title":"The Emerging Role of Epigenetic Modifications and Chromatin Remodeling in Spinal Muscular Atrophy","volume":"109","author":"Lunke","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.cell.2022.04.031","article-title":"Counteracting Chromatin Effects of a Splicing-Correcting Antisense Oligonucleotide Improves Its Therapeutic Efficacy in Spinal Muscular Atrophy","volume":"185","author":"Marasco","year":"2022","journal-title":"Cell"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2217\/epi-2020-0282","article-title":"Epigenetics of Neuromuscular Disorders","volume":"12","year":"2020","journal-title":"Epigenomics"},{"key":"ref_202","unstructured":"(2025, February 25). Riluzole: Package Insert\/Prescribing Information. Available online: https:\/\/www.drugs.com\/pro\/riluzole.html."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2004.01.019","article-title":"Mechanisms Underlying the Riluzole Inhibition of Glutamate Release from Rat Cerebral Cortex Nerve Terminals (Synaptosomes)","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/nmt-2020-0033","article-title":"Riluzole for the Treatment of Amyotrophic Lateral Sclerosis","volume":"10","author":"Saitoh","year":"2020","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_205","first-page":"303","article-title":"Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis","volume":"55","author":"Camu","year":"2000","journal-title":"Therapie"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Cantara, S., Simoncelli, G., and Ricci, C. (2024). Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202402.1738.v1"},{"key":"ref_207","unstructured":"Cerillo, J.L., and Parmar, M. (2025). Tofersen. StatPearls, StatPearls Publishing."},{"key":"ref_208","first-page":"194","article-title":"Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy","volume":"24","author":"Neil","year":"2019","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_209","first-page":"e36197","article-title":"Gene Therapy for Spinal Muscular Atrophy (SMA): A Review of Current Challenges and Safety Considerations for Onasemnogene Abeparvovec (Zolgensma)","volume":"15","author":"Ogbonmide","year":"2023","journal-title":"Cureus"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40263-022-00910-8","article-title":"Risdiplam: A Review in Spinal Muscular Atrophy","volume":"36","author":"Paik","year":"2022","journal-title":"CNS Drugs"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMc2300802","article-title":"Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy","volume":"392","author":"Finkel","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_212","unstructured":"Kaneko, K., Hoskin, J., and Hodis, B. (2025). Primary Lateral Sclerosis. StatPearls, StatPearls Publishing."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001756-200303030-00038","article-title":"Investigation of Mitochondrial Function in Hereditary Spastic Paraparesis","volume":"14","author":"McDermott","year":"2003","journal-title":"Neuroreport"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Bellofatto, M., De Michele, G., Iovino, A., Filla, A., and Santorelli, F.M. (2019). Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00003"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"eabi6896","DOI":"10.1126\/sciadv.abi6896","article-title":"Gene Therapy with AR Isoform 2 Rescues Spinal and Bulbar Muscular Atrophy Phenotype by Modulating AR Transcriptional Activity","volume":"7","author":"Lim","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Rossi Sebastiano, M., Ermondi, G., Sato, K., Otomo, A., Hadano, S., and Caron, G. (2022). Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies. Molecules, 27.","DOI":"10.3390\/molecules27207063"},{"key":"ref_217","first-page":"27","article-title":"Toward Precision Medicine in Amyotrophic Lateral Sclerosis","volume":"4","author":"Zou","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"121153","DOI":"10.1016\/j.lfs.2022.121153","article-title":"Modulating Autophagy and Mitophagy as a Promising Therapeutic Approach in Neurodegenerative Disorders","volume":"311","author":"Mishra","year":"2022","journal-title":"Life Sci."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Bresciani, G., Manai, F., Davinelli, S., Tucci, P., Saso, L., and Amadio, M. (2023). Novel Potential Pharmacological Applications of Dimethyl Fumarate\u2014an Overview and Update. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1264842"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Mayer, C., Riera-Ponsati, L., Kauppinen, S., Klitgaard, H., Erler, J.T., and Hansen, S.N. (2024). Targeting the NRF2 Pathway for Disease Modification in Neurodegenerative Diseases: Mechanisms and Therapeutic Implications. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1437939"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s13311-022-01247-2","article-title":"Antisense Oligonucleotides for the Study and Treatment of ALS","volume":"19","author":"Boros","year":"2022","journal-title":"Neurotherapeutics"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4904\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:35:53Z","timestamp":1760031353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":221,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26104904"],"URL":"https:\/\/doi.org\/10.3390\/ijms26104904","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}